DETERMINING SPECIFIC THYROID TRANSCRIPTS
IN PERIPHERAL BLOOD:
A SINGLE CENTER STUDY EXPERIENCE
Makazlieva T, Eftimov A, Vaskova O, Tripunoski T,
Miladinova D, Risteski S, Jovanovic H, Jakovski Z
Tanja Makazlieva and Aleksandar Eftimov contributed equally to this study
and are considered first coauthors.
*Corresponding Author: Tanja Makazlieva, Ph.D., Institute of Pathophysiology and Nuclear Medicine,
Medical Faculty, Mother Teresa Street, No. 17, 1000, Skopje, Republic of Macedonia.
Mobile: +389-75-313-665. E-mail: tmakazlieva@medf.ukim.edu.mk or tmakazlieva@gmail.com
page: 13
|
|
REFERENCES
1. Li Volsi VA. Papillary thyroid carcinoma: An update.
Mod Pathol. 2011; 24(2): S1-S9.
2. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri
R. Worldwide increasing incidence of thyroid
cancer: Update on epidemiology and risk factors. J
Cancer Epidemiol. 2013; 2013: 965212.
3. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid
carcinoma variants. Head Neck Pathol. 2011; 5(1):
51-56.
4. De Groot LJ, Reed Larsen P, Hennemann G, Editors.
The Thyroid and Its Diseases, 6th ed. New York, NY,
USA: Churchill Livingstone, 1996.
5. Burns WR, Zeiger MA. Differentiated thyroid cancer.
Semin Oncol. 2010; 37(6): 557-66.
6. Verburg FA, Lips CJM, Lentjes EGWM, De Klerk
JMH. Detection of circulating Tg-mRNA in the follow-
up of papillary and follicular thyroid cancer: how
useful is it? Br J Cancer. 2004; 91(2): 200-204.
7. Schlumberger M, Pacini F, Tuttle RM, Editors. Thyroid
Tumors, 4th ed. Paris, France: Institute Medico-
Educatif, 2015. 8. Haugen BR, Alexander EK, Bible KC, Doherty GM,
Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid
Association Management Guidelines for Adult
Patients with Thyroid Nodules and Differentiated
Thyroid Cancer. The American Thyroid Association
Guidelines Task Force on Thyroid Nodules and Differentiated
Thyroid Cancer. Thyroid. 2016; 26(1):
1-133.
9. Andergassen U, Zebisch M, Kölbl AC, König A,
Heublein S, Schröder L, et al. Real-time qPCR-based
detection of circulating tumor cells from blood samples
of adjuvant breast cancer patients: A preliminary
study. Breast Care. 2016; 11(3):194-198.
10. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J,
Feind C, et al. Detection of circulating thyroid cells
in peripheral blood. Surgery. 1996; 120(6): 959-964;
discussion 964-965.(?)
11. Ringel MD. Molecular detection of thyroid cancer:
Differentiating “signal” and “noise” in clinical assays.
J Clin Endocrinol Metab. 2004; 89(1): 29-32.
12. Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R,
Gonen M, et al. Estimating risk of recurrence in differentiated
thyroid cancer after total thyroidectomy
and radioactive iodine remnant ablation: using response
to therapy variables to modify the initial risk
estimates predicted by the new American Thyroid
Association staging system. Thyroid. 2010; 20(12):
1341-1349.
13. Gupta MK, Taguba L, Arciaga R, Siperstein A,
Faiman C, Mehta A, et al. Detection of circulating
thyroid cells by reverse transcription-PCR for thyroid-
stimulating hormone receptor and thyroglobulin:
the importance of primer selection. Clin Chem. 2002;
48(10): 1862-1865.
14. Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein
A, Mehta AE. Detection of thyrotropin-receptor
messenger ribonucleic acid (mRNA) and thyroglobulin
mRNA transcripts in peripheral blood of patients
with thyroid disease: Sensitive and specific markers
for thyroid cancer. J Clin Endocrinol Metab. 2004;
89(8):3705-3709.
15. Livak KJ and Schmittgen TD. Analysis of relative
gene expression data using real-time quantitative PCR
and the 2-ΔΔCT method. Methods. 2001; 25(4):402-408.
16. Rao X, Huang X, Zhou Z, Lin X. An improvement
of the 2-delta deltaCT method for quantitative real-time
polymerase chain reaction data analysis. Biostat Bioinforma
Biomath. 2013; 3(3):71-85.
17. Badulescu IC, Barbus E, Piciu D. Circulating tumor
cells in thyroid carcinoma – The prognostic role of
this biomarker. Review of the literature. Clujul Med.
2017; 90(3):256-261.
18. Barzon L, Boscaro M, Paenti M, Taccaliti A, Palu G.
Evaluation of circulating thyroid-specific transcripts
as markers of thyroid cancer relaps. Int J Cancer.
2004; 110(6): 914-920.
19. Wingo ST, Ringel MD, Anderson JS, Patel AD, Lukes
YD, Djuh YY, et al. Quantitative reverse trans-cription-
PCR measurement of thyroglobulin mRNA in
peripheral blood of healthy subjects. Clin Chem.
1999; 45(6 Pt 1):785-789.
20. Teama SH, Agwa SHA, Fawzy A, Sayed MM, Ibrahim
WA, Eid YM. Molecular detection of circulating
thyroid specific transcripts (TSHR/Tg-mRNAs) in
thyroid cancer patients: Their diagnostic significance.
Egypt J Med Hum Genet. 2011; 12(2): 201-209.
21. Gupta M, Chia SY. Circulating thyroid cancer markers.
Curr Opin Endocrinol Diabetes Obes. 2007;
14(5): 383-388.
22. Eszlinger M, Neumann S, Otto L, Paschke R. Threoglobulin
mRNA quantification in the peripheral blood
is not a reliable marker for the follow-up of the patients
with differentiated thyroid cancer. Eur J Endocrinol.
2002; 147(5): 575-582.
23. Ringel MD, Balducci-Silano PL, Anderson JS, Spencer
CA, Silverman J, Sparling YH, et al. Quantitative
reverse transcription-PCR of circulating thyroglobulin
messenger ribonucleic acid for monitoring patients
with thyroid carcinoma. J Clin Endocrinol Metab.
1999; 84(11): 4037-4042.
24. Bojunga J, Röddiger S, Stanisch M, Kusterer K, Kurek
R, Renneberg H, et al. Molecular detection of
thyroglobulin mRNA transcripts in peripheral blood
of patients with thyroid disease by RT-PCR. Br J
Cancer. 2000; 82(10): 1650–1655.
25. Takano T, Miyauchi A, Yoshida H, Hasegawa Y,
Kuma K, Amino N. Quantitative measurement of
thyroglobulin mRNA in peripheral blood of patients
after total thyroidectomy. Br J Cancer. 2001; 85(1):
102-106.
26. Savagner F, Rodien P, Reynier P, Rohmer V, Bigorgne
JC, Malthiery Y. Analysis of Tg transcripts by real
time RT PCR in blood of thyroid cancer patients. J
Clin Endocrinol Metab. 2002; 87(2): 635-639.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
